Fundraising FoxCarisma Therapeutics
Philadelphia, US · Founded 2017 · Delaware corporation · 13 known investors
Find your way into Carisma Therapeutics
Sign up to see every warm intro you have to Carisma Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Carisma Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
Founders & leadership
Board
Investors · 13
How we know: Agent Capital's portfolio page · a partner's Signal profile · board seat on SEC Form D · prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Anzu Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: prnewswire.com · Not right? Tell us
How we know: HealthCap's portfolio page · prnewswire.com · Not right? Tell us
How we know: MRL Ventures Fund's portfolio page · prnewswire.com · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 3
Reported raises · per SEC filings
Form D private placements$95M disclosed across 3 rounds · 2017–2020
▶$38.3MraisedJan 2021 · 13 investors · BiotechnologyRule 506(b)
- Briggs MorrisonDirector
- Jacob GunterbergDirector
- Regina HoditsDirector
- Michael HeffernanDirector
- Chidozie UgwumbaDirector
- Margarita ChavezDirector
- Steven KellyExecutive Officer, Director
- Offering amount
- $70.4M
- Amount sold
- $38.3M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$52.9MraisedJul 2020 · 11 investors · BiotechnologyRule 506(b)
- Steven KellyExecutive Officer, Director
- Margarita ChavezDirector
- Eran NadavDirector
- Althea StillmanDirector
- Jacob GunterbergDirector
- Regina HoditsDirector
- Offering amount
- $52.9M
- Amount sold
- $52.9M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$3.9MraisedApr 2018 · 7 investors · BiotechnologyRule 506(b)
- Margarita ChavezDirector
- Steven KellyExecutive Officer, Director
- Bruce PeacockDirector
- Michael PoiselDirector
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Carisma Therapeutics went on to found or lead other companies.
Related companies · 3
Companies working in the same space as Carisma Therapeutics.
In the news
Frequently asked questions
- What does Carisma Therapeutics do?
- CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
- Who are Carisma Therapeutics's investors?
- Carisma Therapeutics's investors include Agent Capital, Aju IB Investment, Anzu Partners, Grazia Equity GmbH, HealthCap, MRL Ventures Fund, Solasta Ventures, AbbVie and 2 more.
- How much funding has Carisma Therapeutics raised?
- Carisma Therapeutics has disclosed $95M raised across 3 rounds.
- Where is Carisma Therapeutics headquartered?
- Carisma Therapeutics is headquartered in Philadelphia, US.